Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.48 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dibutylsuccinate SCHEMBL28147008 | 1.00 | DGKA (0.57) | DGKAHTR2CALDH1A1NAAAPAM | |
| Hydrochloric Acid SCHEMBL9414457 | 0.98 | DGKA (0.55) | DGKAHTR2CALDH1A1NAAAPAM | |
| Adipic Acid SCHEMBL5137402 | 0.96 | DGKA (0.59) | DGKAHTR2CALDH1A1PAMAKR1B1 | |
| Dibutylsuccinate SCHEMBL27564311 | 0.94 | DGKA (0.61) | DGKAHTR2CALDH1A1PAMAKR1B1 | |
| SCHEMBL19557 | 0.94 | HTR2C (0.62) | DGKAHTR2CALDH1A1NAAAPAM | |
| Succinic Acid SCHEMBL27572777 | 0.94 | DGKA (0.67) | DGKAALDH1A1PAMAKR1B1GPR84 | |
| Butyl Alcohol SCHEMBL9131216 | 0.92 | DGKA (0.50) | DGKAHTR2CALDH1A1NAAAPAM | |
| Ether SCHEMBL12980698 | 0.92 | DGKA (0.50) | DGKAHTR2CALDH1A1NAAAPAM | |
| SCHEMBL10868296 | 0.92 | HTR2C (0.66) | DGKAHTR2CALDH1A1NAAAPAM | |
| Dibutylsuccinate SCHEMBL7758479 | 0.92 | DGKA (0.59) | DGKAHTR2CALDH1A1PAMAKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695329-A1 | CELLULOSE ESTER COMPOSITIONS WITH FLOW AID | Eastman Chemical Company (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4673295-A1 | RECOVERY OF VAPORS AND LIQUIDS FROM SHEET PRODUCTION PROCESS | Eastman Chemical Company (US) | 2026-01-07 | — | — | EP | claimed |
| WO-2025136904-A1 | INJECTION MOLDED ARTICLES AND METHODS OF MANUFACTURING THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2025-06-26 | — | — | WO | claimed |
| WO-2025136900-A1 | CO-LOCATION OF CELLULOSE ESTER PROCESSING SYSTEMS | EASTMAN CHEMICAL COMPANY (US) | 2025-06-26 | — | — | WO | claimed |
| WO-2025087854-A1 | BLADE, PROPELLER AND FAN DIFFUSING A SEMIOCHEMICAL SUBSTANCE, AND CORRESPONDING FACILITY AND USE | MELCHIOR MATERIAL AND LIFE SCIENCE FRANCE (FR) | 2025-05-01 | — | — | WO | claimed |
| WO-2025026751-A1 | MICROCIRCUIT BOARD | IDEMIA FRANCE (FR) | 2025-02-06 | — | — | WO | claimed |
| US-20250002694-A1 | MELT PROCESSABLE CELLULOSE ESTER COMPOSITIONS COMPRISING AMORPHOUS BIOFILLER | EASTMAN CHEMICAL COMPANY (US) | 2025-01-02 | — | — | US | claimed |
| US-20240425682-A1 | ARTICLES COMPRISING MELT PROCESSABLE CELLULOSE ACETATE COMPOSITIONS COMPRISING AMORPHOUS BIOFILLER | EASTMAN CHEMICAL COMPANY (US) | 2024-12-26 | — | — | US | claimed |
| US-20240425681-A1 | ARTICLES CONTAINING MELT PROCESSABLE CELLULOSE ESTER COMPOSITIONS COMPRING AMORPHOUS BIOFILLER | EASTMAN CHEMICAL COMPANY (US) | 2024-12-26 | — | — | US | claimed |
| US-20240409722-A1 | PROCESS FOR MAKING MELT PROCESSABLE CELLULOSE ESTER COMPOSITIONS COMPRISING AMORPHOUS BIOFILLER | EASTMAN CHEMICAL COMPANY (US) | 2024-12-12 | — | — | US | claimed |
| US-7060301-B2 | In situ mono-or diester dicarboxylate compositions | ECOLAB INC. (US) | 2006-06-13 | — | — | US | claimed |
| US-6983801-B2 | Well treatment fluid compositions and methods for their use | BJ SERVICES COMPANY (US) | 2006-01-10 | — | — | US | claimed |
| US-20050288399-A1 | Biodegradable plastic composition and producing method thereof | CHEN MING-TUNG | 2005-12-29 | — | — | US | claimed |
| CN-1678961-A | Removing solution | DAIKIN IND LTD (JP) | 2005-10-05 | — | — | CN | claimed |
| EP-1536291-A1 | REMOVING SOLUTION | Daikin Industries, Ltd. (JP) | 2005-06-01 | — | — | EP | claimed |
| US-20050016733-A1 | Well treatment fluid compositions and methods for their use | COMBINED SYSTEMS, INC. | 2005-01-27 | — | — | US | claimed |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | ECOLAB USA INC. | 2003-01-30 | — | — | US | claimed |
| WO-2003005818-A1 | IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | claimed |
| US-20020125012-A1 | Well treatment fluid compositions and methods for their use | BJ SERVICES COMPANY | 2002-09-12 | — | — | US | claimed |
| WO-2002055843-A1 | WELL TREATMENT FLUID COMPOSITIONS AND METHODS FOR THEIR USE | BJ SERVICES COMPANY (US) | 2002-07-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | DDC, HCAR3, ACMSD | DGKA 109/4885HTR2C 4223/4885ALDH1A1 590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.